IonQ, Inc. filings document a public quantum technology company with common stock, warrants and recurring capital-structure disclosures. Its 8-K reports include operating and financial results, material-event updates, registration rights agreements, unregistered equity issuances, resale prospectus supplements and acquisition-related share issuances, including the completed Skyloom Global acquisition.
IonQ proxy materials cover shareholder voting matters, board governance, executive compensation and pay-versus-performance disclosures. The company’s filing record also reflects material agreements, warrant and common-stock terms, financial reporting furnished with earnings releases, and governance matters connected to its quantum computing, networking, sensing, security and space-based data businesses.
IonQ Chief Financial Officer Thomas G. Kramer has executed a significant stock transaction on June 16, 2025, selling 216,000 shares of common stock at a weighted average price of $38.1131 per share. The transaction was conducted through a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025.
Following the transaction, Kramer retains direct ownership of 718,516 shares and indirect ownership of 5 shares through his child. The sales were executed at prices ranging from $36.07 to $39.14 per share.
Key transaction details:
- Transaction was executed pursuant to a Rule 10b5-1 plan, indicating pre-planned, scheduled trading activity
- Total transaction value approximately $8.23 million
- Significant retained ownership position indicates continued alignment with shareholder interests
- Filing was signed by attorney-in-fact Stacey Giamalis on June 18, 2025
IonQ Executive Chair Peter Chapman reported significant insider transactions executed through a pre-planned Rule 10b5-1 trading plan established on March 14, 2025. The transactions occurred over two consecutive days:
- On June 16, 2025: Exercised 3,581,193 stock options at $0.1334 per share and subsequently sold them at an average price of $38.126
- On June 17, 2025: Exercised 910,740 stock options at $0.1334 per share and sold them at an average price of $37.7787
Following these transactions, Chapman retains 390,329 shares of common stock held directly and 1,604,972 vested stock options exercisable until May 16, 2029. The substantial price difference between the exercise price ($0.1334) and sale prices (>$36) resulted in significant gains. These pre-planned sales may indicate portfolio diversification rather than a lack of confidence in the company.